Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distribu...

FDA Recall #D-0327-2024 — Class II — February 13, 2024

Recall #D-0327-2024 Date: February 13, 2024 Classification: Class II Status: Terminated

Product Description

Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6

Reason for Recall

Failed Impurities/Degradation Specifications: Out-of-specification test results.

Recalling Firm

Amneal Pharmaceuticals of New York, LLC — Brookhaven, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

46,037 Bottles

Distribution

Nationwide in the USA

Code Information

Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated